By Manav Shaileshkumar Mistry. The Kennedy College of Sciences, Miner School of Computer and Information Sciences, invites you to attend a Master’s thesis defense by ...

Rahul Banerjee, MD, discusses the most relevant multiple myeloma treatment options presented at the EHA Congress 2026.

Rituximab and ocrelizumab go head to head in randomized trial ...

If you have poor mental health symptoms or feel like your brain isn't as sharp as it used to be, you’re not alone. About 25% of people with multiple myeloma report serious mental distress and ...

Learn the common mistakes of using one Apple Account on multiple iPhones, including iCloud syncing, Messages, FaceTime, Find My, and security risks. Using the same Apple Account on multiple iPhones ...

Plasmapheresis is an uncommon treatment that can be used to manage something called myeloma kidney, a type of kidney failure that affects many people with multiple myeloma. It separates out plasma ...

MANGROVE is the first phase 3 trial positioning a chemotherapy-free regimen as a potential frontline standard for MCL, addressing long-term toxicity concerns associated with chemoimmunotherapy.

Extended follow-up showed median OS of 21.2 months, 41% OS at 24 months, and 33% OS at three years, suggesting a late Kaplan–Meier plateau. Confirmed ORR reached 21% with 3 complete responses; median ...